Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity sc...
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study
About this item
Full title
Author / Creator
Kister, Ilya , Spelman, Tim , Alroughani, Raed , Lechner-Scott, Jeannette , Duquette, Pierre , Grand'Maison, Francois , Slee, Mark , Lugaresi, Alessandra , Barnett, Michael , Grammond, Pierre , Iuliano, Gerardo , Hupperts, Raymond , Pucci, Eugenio , Trojano, Maria , Butzkueven, Helmut and MSBase Study Group
Publisher
England: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
BackgroundDiscontinuation of injectable disease-modifying therapy (DMT) for multiple sclerosis (MS) after a long period of relapse freedom is frequently considered, but data on post-cessation disease course are lacking.Objectives(1) To compare time to first relapse and disability progression among ‘DMT stoppers’ and propensity-score matched ‘DMT st...
Alternative Titles
Full title
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1820593811
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1820593811
Other Identifiers
ISSN
0022-3050
E-ISSN
1468-330X
DOI
10.1136/jnnp-2016-313760
